Patients with COVID‐19 tend to have multiple organ dysfunction and hypoglycaemia induced increase of adrenaline, corticosteroids, growth hormone and glucagon as well as dysregulated blood glucose homeostasis might together exacerbate the patients’ condition. This evidence concerns the gene GH1 and COVID-19.